Metric Finance
LearnFAQ
LearnFAQ

Learn / ALGN

NASDAQ: ALGN

Align Technology (ALGN) stock, explained like you're 5

Align Technology trades on the Nasdaq under the ticker ALGN. It is a large cap company in the industrial specialties industry, part of the healthcare sector, with a market value of about 10.1 billion dollars.

Ticker
ALGN
Exchange
Nasdaq
Sector
Healthcare
Industry
Industrial Specialties
Size
Large cap, about 10.1 billion dollars

Is Align Technology a small, medium or large cap company?

Yes. Align Technology is a large cap stock. Its market cap, which is the total value of all its shares, is about 10.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Align Technology makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ALGN stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Align Technology Wins Significant Patent Infringement Case Against Angelalign at Unified Patent Court (Stock Titan)
  • Align Technology Inc. stock outperforms competitors on strong trading day (MarketWatch)
  • Align Technology, Inc. (ALGN) Stock forecasts (Yahoo Finance Australia)
  • Digital Dentistry Growth Might Change The Case For Investing In Align Technology (ALGN) (Simply Wall Street)
  • ALGN: Align Technology, Inc. Latest Stock Price, Analysis, News and Trading Ideas (Stocktwits)

Follow ALGN in your daily brief

Each trading day at 5 PM ET we post what happened to Align Technology and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ALGN

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Align Technology stock

What does Align Technology do?

Align Technology trades on the Nasdaq under the ticker ALGN. It is a large cap company in the industrial specialties industry, part of the healthcare sector, with a market value of about 10.1 billion dollars.

What is the ticker symbol for Align Technology?

Align Technology trades under the ticker ALGN on the Nasdaq.

What is Align Technology's market cap?

Align Technology is a large cap stock with a market cap of about 10.1 billion dollars.

How does Align Technology make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ALGN stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ALGN stock every day?

Add ALGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ALGN daily

A free brief on Align Technology and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • STE · STERIS plc
  • ZBH · Zimmer Biomet Holdings
  • MAS · Masco Corp /De/
  • AIT · Applied Industrial Technologies

Similar stocks

  • STESTERIS plc
  • ZBHZimmer Biomet Holdings
  • MASMasco Corp /De/
  • AITApplied Industrial Technologies

Compare ALGN: ALGN vs STE, ALGN vs ZBH, ALGN vs MAS

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed